cas 131748-14-6|| where to buy 4-Chloro-2-(trifluoromethyl)pyridine

Nom du produit:4-Chloro-2-(trifluoromethyl)pyridine

IUPAC Name:4-chloro-2-(trifluoromethyl)pyridine

Unité d'emballage	Stock disponible	Prix($)
CM120691-25g	in stock	ǧƙ
CM120691-100g	in stock	ȬƀȬ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 131748-14-6 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:131748-14-6; Formule moléculaire:C6H3ClF3N; Point de fusion:-; Code SMILES:FC(C1=NC=CC(Cl)=C1)(F)F; Densité:

: Numéro de catalogue:CM120691; Poids moléculaire:181.54; Point d'ébullition:; N° Mdl:MFCD07368047; Stockage:

: Pyridines; Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.; Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu; Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer; Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.

: Emraclidine; Emraclidine is a novel, brain-penetrant, highly selective M4 receptor positive allosteric modulator(PAM) in development for the treatment of schizophrenia.
We believe emraclidine has the potential to provide a significant medical advancement as the muscarinic acetylcholine pathway has long been associated with mediation of neurotransmitter imbalance and psychosis. Emraclidine is the only selective M4 receptor PAM currently in clinical development.